Detalles de la búsqueda
1.
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.
Br J Cancer
; 130(2): 233-241, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37996507
2.
Early inhibition of endothelial retinoid uptake upon myocardial infarction restores cardiac function and prevents cell, tissue, and animal death.
J Mol Cell Cardiol
; 126: 105-117, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30472251
3.
Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077.
Br J Haematol
; 162(2): 202-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23692564
4.
Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study.
J Cancer Res Clin Oncol
; 149(7): 3739-3752, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35987926
5.
Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.
BMC Cancer
; 12: 356, 2012 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22897915
6.
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV).
J Cancer Res Clin Oncol
; 147(8): 2349-2359, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33433659
7.
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
J Cancer Res Clin Oncol
; 143(12): 2545-2553, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28828689
8.
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
J Cancer Res Clin Oncol
; 141(11): 2013-22, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25976868
9.
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
J Cancer Res Clin Oncol
; 140(11): 1947-56, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942335
10.
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
J Cancer Res Clin Oncol
; 139(3): 499-508, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23184429
11.
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
J Cancer Res Clin Oncol
; 139(11): 1937-46, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24046251
Resultados
1 -
11
de 11
1
Próxima >
>>